ESPIZENE CONTINU 3 mg/0.02 mg, film-coated tablet 84 tablets
Active ingredients: Drospirenone, Ethinylestradiol
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet84 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ESPIZENE CONTINU 3 mg/0,02 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé et comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 3 plaquette(s) aluminium PVC PVDC de 28 comprimés
- Marketing authorisation holder
- EXELTIS SANTE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 26 May 2014
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63822272CIP72692278CIP133400926922788Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉTHINYLESTRADIOLcomprimé actif rose | 0,02 mg · un comprimé | SA |
| DROSPIRÉNONEcomprimé actif rose | 3 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.